| Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells CC Kloss, M Condomines, M Cartellieri, M Bachmann, M Sadelain Nature biotechnology 31 (1), 71-75, 2013 | 1103 | 2013 |
| Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia A Ehninger, M Kramer, C Röllig, C Thiede, M Bornhäuser, M Von Bonin, ... Blood cancer journal 4 (6), e218-e218, 2014 | 419 | 2014 |
| Nuclear localization of the protein encoded by the Wilms’ tumor gene WT1 in embryonic and adult tissues S Mundlos, J Pelletier, A Darveau, M Bachmann, A Winterpacht, B Zabel Development 119 (4), 1329-1341, 1993 | 396 | 1993 |
| Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses A Hänsel, C Günther, J Ingwersen, J Starke, M Schmitz, M Bachmann, ... Journal of Allergy and Clinical Immunology 127 (3), 787-794. e9, 2011 | 299 | 2011 |
| Chimeric antigen receptor‐engineered T cells for immunotherapy of cancer M Cartellieri, M Bachmann, A Feldmann, C Bippes, S Stamova, R Wehner, ... BioMed Research International 2010 (1), 956304, 2010 | 292 | 2010 |
| Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts M Cartellieri, A Feldmann, S Koristka, C Arndt, S Loff, A Ehninger, ... Blood cancer journal 6 (8), e458-e458, 2016 | 290 | 2016 |
| DAP12-based activating chimeric antigen receptor for NK cell tumor immunotherapy K Töpfer, M Cartellieri, S Michen, R Wiedemuth, N Müller, D Lindemann, ... The Journal of Immunology 194 (7), 3201-3212, 2015 | 286 | 2015 |
| Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy M Schmitz, A Temme, V Senner, R Ebner, S Schwind, S Stevanovic, ... British journal of cancer 96 (8), 1293-1301, 2007 | 271 | 2007 |
| Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders S Zhao, R Wehner, M Bornhäuser, R Wassmuth, M Bachmann, M Schmitz Stem cells and development 19 (5), 607-614, 2010 | 262 | 2010 |
| Oxidatively modified autoantigens in autoimmune diseases BT Kurien, K Hensley, M Bachmann, RH Scofield Free Radical Biology and Medicine 41 (4), 549-556, 2006 | 255 | 2006 |
| Tumor evasion from T cell surveillance K Töpfer, S Kempe, N Müller, M Schmitz, M Bachmann, M Cartellieri, ... BioMed Research International 2011 (1), 918471, 2011 | 250 | 2011 |
| The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation VH Nguyen, S Shashidhar, DS Chang, L Ho, N Kambham, M Bachmann, ... Blood, The Journal of the American Society of Hematology 111 (2), 945-953, 2008 | 234 | 2008 |
| The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein J Dedio, W Jahnen-Dechent, M Bachmann, W Muller-Esterl The Journal of Immunology 160 (7), 3534-3542, 1998 | 219 | 1998 |
| Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissues AC Cunha, B Weigle, A Kiessling, M Bachmann, EP Rieber Cancer letters 236 (2), 229-238, 2006 | 194 | 2006 |
| The bidirectional crosstalk between human dendritic cells and natural killer cells R Wehner, K Dietze, M Bachmann, M Schmitz Journal of innate immunity 3 (3), 258-263, 2011 | 176 | 2011 |
| PET/MRI in head and neck cancer: initial experience I Platzek, B Beuthien-Baumann, M Schneider, V Gudziol, J Langner, ... European journal of nuclear medicine and molecular imaging 40 (1), 6-11, 2013 | 168* | 2013 |
| Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells IW Jeffrey, S Kadereit, EF Meurs, T Metzger, M Bachmann, M Schwemmle, ... Experimental cell research 218 (1), 17-27, 1995 | 167 | 1995 |
| Characterization of the autoantigen La as a nucleic acid-dependent ATPase/dATPase with melting properties M Bachmann, K Pfeifer, HC Schrdder, WEG Müller Cell 60 (1), 85-93, 1990 | 152 | 1990 |
| The UniCAR system: A modular CAR T cell approach to improve the safety of CAR T cells M Bachmann Immunology letters 211, 13-22, 2019 | 138 | 2019 |
| Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T‐cells A Morgenroth, M Cartellieri, M Schmitz, S Günes, B Weigle, M Bachmann, ... The Prostate 67 (10), 1121-1131, 2007 | 134 | 2007 |
Anja FeldmannHelmholtz-Zentrum Dresden-RossendorfVerified email at hzdr.de
